Skip to content
Woolsey Pharmaceuticals
  • Home
  • Indications
    • Dementia Wandering
    • PSP / CBS
    • ALS
    • Expanded Access Policy
  • Team
  • News
  • Contact Us

Drug Repurposing PDF

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download

Post navigation
← Previous Post
Next Post →

Recent Posts

  • Woolsey Pharmaceuticals Receives Positive Opinion on Orphan Drug Application from the European Medicines Agency for the Treatment of ALS with BRAVYL
  • Woolsey Pharmaceuticals Begins ALS Study
  • Woolsey Pharmaceuticals Completes Second Round of Financing
  • Woolsey Pharmaceuticals Emerges from Stealth Mode to Announce Patients Enrolled in Two New CNS Studies
  • Drug Repurposing PDF

Archives

  • January 2022
  • December 2021
  • February 2021
  • November 2020
  • March 2020
Privacy Policy
Copyright © 2022 Woolsey Pharmaceuticals, Inc. / Embark Healthcare, Inc.
Powered by LaunchNeo